Clinical Trials Logo

Clinical Trial Summary

Intravenous thrombolysis is considered as the first choice for ischemic stroke. In the recent years, endovascular therapy is demonstrated to be effective to treat ischemic with big vessel occlusion. However, only a minority of patients can get intravenous thrombolysis or endovascular therapy due to the restricted time window and strict indications. Dual antiplatelet has been demonstrated to be effective in the patients with high risk of TIA or minor ischemic stroke (NIHSS<4). But there is still stroke progression although dual antiplatelet. The ischemic stroke patients with NIHSS > 3 has been recommended to give aspirin in most guidelines. Of those patients, mild to moderate stroke patients (3<NIHSS<10) will result in the poor outcomes if the progression occurs. In addition, large artery atherosclerosis (LAA) stroke is prone to progress. So, we argue that the mild to moderate stroke with LAA should be give more intensive antiplatelet. In the present study, argatroban combined with antiplatelet therapy (3-5 days) is used to treat the proposed patients to investigate the safety and effectiveness.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03552354
Study type Interventional
Source General Hospital of Shenyang Military Region
Status Completed
Phase Phase 4
Start date October 25, 2017
Completion date January 8, 2019

See also
  Status Clinical Trial Phase
Completed NCT01937182 - The Efficacy of Citalopram Treatment in Acute Stroke Phase 2
Recruiting NCT03558659 - Positional Therapy to Treat Obstructive Sleep Apnea in Stroke Patients N/A
Recruiting NCT03839810 - Stochastic Resonance Stimulation in Brain Plasticity and Post Stroke Motor Recovery N/A
Not yet recruiting NCT03648957 - Lifestyle Counselling as Secondary Prevention in Patients With Minor Stroke and Transient Ischemic Attack N/A
Recruiting NCT03699397 - EEG Controlled Triage in the Ambulance for Acute Ischemic Stroke N/A
Not yet recruiting NCT03211130 - Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors Early Phase 1
Not yet recruiting NCT03243318 - Motor Evoked Potential in the Affected Upper Limb Predicts the Potential of Motor Recovery After Ischemic Stroke N/A
Recruiting NCT01716481 - The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study Phase 3
Recruiting NCT03649711 - Chronic Kidney Disease (CKD) Platelet Study Phase 3
Not yet recruiting NCT03724318 - Left Atrium Appendage Closure by Surgery-2 N/A
Completed NCT03621917 - Evaluation of the Effectiveness of Thrombolytic Therapy in Acute Ischemic Stroke Patients Using NIRS
Completed NCT03507517 - Quality Control Project of Stroke in Liaoning Province
Recruiting NCT03394950 - Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Phase 4
Not yet recruiting NCT03814889 - Passive Tactile Stimulation for Stroke Rehabilitation N/A
Not yet recruiting NCT03592563 - CUHK Brain Health Longitudinal Study
Not yet recruiting NCT03884166 - MUcociliary Clearance IN Stroke
Active, not recruiting NCT03038685 - A Personalized, Digital Coaching Program After Stroke N/A
Completed NCT03334968 - Prolidase Enzyme Activity in Stroke Patients N/A
Terminated NCT03764306 - New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis N/A
Suspended NCT03098732 - Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial N/A